Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma
Clinical trial NCT02331368 · COMPLETED
Trial details
- NCT number
- NCT02331368
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-06-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.